- Dr. Anthony Fauci told presenter Chuck Todd on NBC’s “Meet the Press” that the United States is “months” away from a coronavirus vaccine approved for children.
- During vaccine development, it is normal for children to be studied after adults so that researchers can be sure of the safety of the shots, and vaccination studies have so far mainly involved adult participants.
- Fauci estimated that the process of approving vaccinations against children would begin in January.
- This is likely to be smooth when schools reopen, as several cities have suspended or abandoned plans to resume personal classes.
- Visit the Business Insider website for more news.
Dr. Anthony Fauci warned on Sunday that vaccination of children is only likely after January.
Fauci, a world-renowned expert on infectious diseases and long-term director of the National Institute of Allergy and Infectious Diseases, told presenter Chuck Todd on NBC’s “Meet the Press,” authorities are likely to begin the process in January to obtain it. more for the kids sooner rather than later. ”
While pharmaceutical manufacturers Pfizer, Moderna and AstraZeneca recently announced promising results on their shots, they have not yet obtained a distribution direction from the U.S. Food and Drug Administration, which requires more safety data, Business Insider Andrew Dunn wrote earlier.
Early admissions are likely to be given to health workers and the elderly, Fauci said, but other adults may be vaccinated as early as April or June, depending on who they ask. But in order to get permission to sell vaccines to children, additional safety data and studies are needed.
This is likely to close when schools reopen, as several cities have suspended or abandoned plans to resume personal classes. Earlier this month, Mayor Bill de Blasio closed schools in New York – in many cases returning students to his parents for home schooling – as the city achieved a 3% test positivity rate for the coronavirus.
“Children as well as pregnant women are vulnerable,” Fauci told NBC. “So before you put it in children, you need to make sure it has efficacy and safety that is proven by an adult population, especially an adult normal population.”
Vaccine trials to date have mainly involved adult participants, so vaccine development generally works. Researchers start with young and healthy adults before expanding into more vulnerable groups, Dunn reported in September.
In late October, Pfizer extended its trial to 12-year-olds. Moderna is still trying to extend the trial to teenagers, but Tal Zaks, the doctor’s chief physician, told Axios that a vaccine could be ready in the middle of next year.
“There will be months,” Fauci said Sunday.
The next steps According to Fauci, I and II. Phase trials, with testing more and more patients followed by a bridge study, are a research method that generally allows drugs authorized in one region of the world to be used in another.
“You could say okay, we’re safe in children now, our immunogenicity is comparable, namely the same type of immune response – we can quickly allow this for children before we pass a 30,000-person trial that can take longer.”